NantKwest, Inc. (54) | Business Finance (14)
Browse by Subcategory
Recent Contracts
-
Purchase Agreement, by and between Athenex, Inc. and ImmunityBio, Inc. dated as of January 7, 2022
(Filed With SEC on January 12, 2022)
-
Promissory Note by and between the Company and Nant Capital, LLC dated as of December 17, 2021
(Filed With SEC on December 20, 2021)
-
Common Stock Purchase Warrant, dated June 30, 2016, issued by ImmunityBio, Inc. to NantWorks, LLC
(Filed With SEC on January 19, 2021)
-
Assignment Agreement, dated July 31, 2017, by and between ImmunityBio, Inc. and NantOmics, LLC
(Filed With SEC on January 19, 2021)
-
Common Stock Purchase Agreement, dated April 30, 2018, by and among ImmunityBio, Inc. and NantBio, Inc
(Filed With SEC on January 19, 2021)
-
Underwriting Agreement, dated June 24, 2020
(Filed With SEC on June 25, 2020)
-
Membership Interest Purchase Agreement entered into as of September 27, 2021, by and among Nant Capital, LLC and ImmunityBio, Inc
(Filed With SEC on November 12, 2021)
-
Promissory Note, dated February 22, 2021, issued by NantCell, Inc. (f/k/a ImmunityBio, Inc.) to Nant Capital, LLC
(Filed With SEC on March 10, 2021)
-
Amended and Restated Promissory Note, dated July 28, 2020, issued by ImmunityBio, Inc. to Nant Capital, LLC
(Filed With SEC on January 19, 2021)
-
Amended and Restated Promissory Note, dated July 28, 2020, issued by ImmunityBio, Inc. to NantWorks, LLC
(Filed With SEC on January 19, 2021)
-
Amended and Restated Promissory Note, dated July 28, 2020, issued by ImmunityBio, Inc. to NantCancerStemCell, LLC
(Filed With SEC on January 19, 2021)
-
Amended and Restated Promissory Note, dated July 28, 2020, issued by ImmunityBio, Inc. to NantMobile, LLC
(Filed With SEC on January 19, 2021)
-
Promissory Note, dated September 30, 2020, issued by ImmunityBio, Inc. to Nant Capital, LLC
(Filed With SEC on January 19, 2021)
-
Assignment Agreement, dated July 2, 2017, by and between NantPharma, LLC and Immunotherapy NANTibody, LLC
(Filed With SEC on January 19, 2021)